Fimlab Laboratories Ltd has selected Aiforia Technologies Plc as the provider for breast and prostate cancer diagnostics solutions. Aiforia Technologies Plc, August 1, 2024 at 09:00 am EEST -- Fimlab Laboratories Ltd has selected Aiforia...

Paige: The newly open-sourced foundation models accelerate cancer innovation with unprecedented access to the most trusted and advanced AI technology available today NEW YORK August 01, 2024 --(BUSINESS WIRE)--Paige, a pioneer in AI-driven...

Proscia: New KLAS Research report and research study conducted with Quest Diagnostics highlight company’s customer and product momentum PHILADELPHIA – JUNE 26, 2024 – Proscia®, a global leader in AI-enabled pathology solutions for...

NEW YORK – Cota, PreciseDx, and Baptist Health South Florida on Wednesday said they are collaborating to validate PreciseDx's PreciseBreast test to predict the likelihood of invasive breast cancer recurrence. Cota, which is based in...

PreciseDx: The poster presentation features findings from PreciseDx's collaboration with the Laboratory of Pathology, Dordrecht Albert Schweitzer Hospital in the Netherlands. NEW YORK, May 28, 2024 /PRNewswire/ -- PreciseDx®, a leading...

Linköping, Sweden – April 29, 2024 – International medical imaging IT and Cybersecurity company Sectra’s (STO: SECT B) digital pathology solution together with Leica Biosystems, Imaging, Inc.’s Aperio GT 450 DX have received a 510(k)...